36 employees
ImmunoACT is an advanced cell and gene therapy startup.
$9.7M
from 2 investors over 2 rounds
ImmunoACT raised $9.7M on May 31, 2023
Investors: Laurus Labs Limited
ImmunoACT raised $7.5M on November 19, 2021